1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine

C207H158N6 — CID 161068614

About 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine

1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine (PubChem CID 161068614) has the molecular formula C207H158N6 and a molecular weight of 2729.58 g/mol. Its IUPAC name is 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine.

Molecular Properties

• Compound Name: 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine
• PubChem CID: 161068614
• Molecular Formula: C207H158N6
• Molecular Weight: 2729.58 g/mol
• Exact Mass: 2727.25
• IUPAC Name: 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine
• SMILES: CN1c2ccccc2C(C)(C)c2c(-c3cccc4c(-c5ccc6cc7ccccc7cc6c5)c5cccc(-c6cccc7c6C(C)(C)c6ccccc6N7C)c5cc34)cccc21.CN1c2ccccc2C(C)(C)c2cccc(-c3cccc4c(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)c5cccc(-c6cccc7c6N(C)c6ccccc6C7(C)C)c5cc34)c21.Cc1cccc2cc3cc(-c4c5cccc(-c6cccc7c6C(c6ccccc6)(c6ccccc6)c6ccccc6N7C)c5cc5c(-c6cccc7c6C(c6ccccc6)(c6ccccc6)c6ccccc6N7C)cccc45)ccc3cc12
• InChI: InChI=1S/C81H58N2.C66H52N2.C60H48N2/c1-53-25-20-26-55-49-57-50-56(48-47-54(57)51-68(53)55)77-64-37-21-35-62(66-39-23-45-75-78(66)80(58-27-8-4-9-28-58,59-29-10-5-11-30-59)71-41-16-18-43-73(71)82(75)2)69(64)52-70-63(36-22-38-65(70)77)67-40-24-46-76-79(67)81(60-31-12-6-13-32-60,61-33-14-7-15-34-61)72-42-17-19-44-74(72)83(76)3;1-65(2)54-34-14-16-38-58(54)67(5)63-50(32-20-36-56(63)65)42-28-18-30-48-52(42)40-53-43(51-33-21-37-57-64(51)68(6)59-39-17-15-35-55(59)66(57,3)4)29-19-31-49(53)62(48)61-46-26-12-10-24-44(46)60(41-22-8-7-9-23-41)45-25-11-13-27-47(45)61;1-59(2)50-25-9-11-27-52(50)61(5)54-29-15-23-46(57(54)59)42-19-13-21-44-48(42)36-49-43(47-24-16-30-55-58(47)60(3,4)51-26-10-12-28-53(51)62(55)6)20-14-22-45(49)56(44)40-32-31-39-33-37-17-7-8-18-38(37)34-41(39)35-40/h4-52H,1-3H3;7-40H,1-6H3;7-36H,1-6H3
• InChIKey: UEJAQGAMZXKLMV-UHFFFAOYSA-N
• XLogP: 54.43
• TPSA: 19.44 Ų
• H-Bond Acceptors: 6
• Rotatable Bonds: 14
• Heavy Atoms: 213
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	2729.58
LogP ≤ 5	54.43
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	6

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine?

The IUPAC name of 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine (CID 161068614) is 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine.

What is the SMILES notation for 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine?

The canonical SMILES for 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine is CN1c2ccccc2C(C)(C)c2c(-c3cccc4c(-c5ccc6cc7ccccc7cc6c5)c5cccc(-c6cccc7c6C(C)(C)c6ccccc6N7C)c5cc34)cccc21.CN1c2ccccc2C(C)(C)c2cccc(-c3cccc4c(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)c5cccc(-c6cccc7c6N(C)c6ccccc6C7(C)C)c5cc34)c21.Cc1cccc2cc3cc(-c4c5cccc(-c6cccc7c6C(c6ccccc6)(c6ccccc6)c6ccccc6N7C)c5cc5c(-c6cccc7c6C(c6ccccc6)(c6ccccc6)c6ccccc6N7C)cccc45)ccc3cc12.

What is the InChIKey of 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine?

The InChIKey is UEJAQGAMZXKLMV-UHFFFAOYSA-N. The full InChI is InChI=1S/C81H58N2.C66H52N2.C60H48N2/c1-53-25-20-26-55-49-57-50-56(48-47-54(57)51-68(53)55)77-64-37-21-35-62(66-39-23-45-75-78(66)80(58-27-8-4-9-28-58,59-29-10-5-11-30-59)71-41-16-18-43-73(71)82(75)2)69(64)52-70-63(36-22-38-65(70)77)67-40-24-46-76-79(67)81(60-31-12-6-13-32-60,61-33-14-7-15-34-61)72-42-17-19-44-74(72)83(76)3;1-65(2)54-34-14-16-38-58(54)67(5)63-50(32-20-36-56(63)65)42-28-18-30-48-52(42)40-53-43(51-33-21-37-57-64(51)68(6)59-39-17-15-35-55(59)66(57,3)4)29-19-31-49(53)62(48)61-46-26-12-10-24-44(46)60(41-22-8-7-9-23-41)45-25-11-13-27-47(45)61;1-59(2)50-25-9-11-27-52(50)61(5)54-29-15-23-46(57(54)59)42-19-13-21-44-48(42)36-49-43(47-24-16-30-55-58(47)60(3,4)51-26-10-12-28-53(51)62(55)6)20-14-22-45(49)56(44)40-32-31-39-33-37-17-7-8-18-38(37)34-41(39)35-40/h4-52H,1-3H3;7-40H,1-6H3;7-36H,1-6H3.

What are the key properties of 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine?

1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine has a molecular weight of 2729.58 g/mol, XLogP of 54.43, 14 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.

Where does this data come from?

All data for 1-[10-anthracen-2-yl-8-(9,9,10-trimethylacridin-1-yl)anthracen-1-yl]-9,9,10-trimethylacridine;10-methyl-1-[10-(5-methylanthracen-2-yl)-8-(10-methyl-9,9-diphenylacridin-1-yl)anthracen-1-yl]-9,9-diphenylacridine;9,9,10-trimethyl-4-[10-(10-phenylanthracen-9-yl)-8-(9,9,10-trimethylacridin-4-yl)anthracen-1-yl]acridine is sourced from PubChem (CID 161068614), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).